EUVIMEDEUVIMED entdecken
Open Access

Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9‐producing CD4 + T cells

Jiho Sohn, Lu Li, Lixia Zhang, Rajendra P Settem iD, Kiyonobu Honma, Ashu Sharma iD, Karen L Falkner, Jan M Novak, Yijun Sun, Keith L Kirkwood iD

Molecular Oral Microbiology · 2022-04 · 37 (2) · 42-52

DOI: 10.1111/omi.12359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oral Microbiology, online erschienen am 07.01.2022. Verfasst von Jiho Sohn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Genetics, Genomics, and Bioinformatics Program, State University of New York at Buffalo, Buffalo, New York. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Inflammatory Bowel Diseases, Periodontal Diseases. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent epidemiological studies have shown that inflammatory bowel disease is associated with periodontal disease. The oral–gut microbiota axis is a potential mechanism intersecting the two diseases. Porphyromonas gingivalis is currently considered a keystone oral pathogen involved in periodontal disease pathogenesis and disease progression. Recent studies have shown that oral ingestion of P. gingivalis leads to intestinal inflammation. However, the molecular underpinnings of P. gingivalis ‐mediated gut inflammation have remained elusive. In this study, we show that the oral administration of P. gingivalis indeed leads to ileal inflammation and alteration in gut microbiota with significant reduction in bacterial alpha diversity despite the absence of P. gingivalis in the lower gastrointestinal tract. Utilizing an antibiotic‐conditioned mouse model, cecal microbiota transfer experiments were performed to demonstrate that P. gingivalis ‐induced dysbiotic gut microbiota is sufficient to reproduce gut pathology. Furthermore, we observed a significant expansion in small intestinal lamina propria IL9 + CD4 + T cells, which was negatively correlated with both bacterial and fungal alpha diversity, signifying that P. gingivalis ‐mediated intestinal inflammation may be due to the subsequent loss of gut microbial diversity. Finally, we detected changes in gene expression related to gut epithelial barrier function, showing the potential downstream effect of intestinal IL9 + CD4 + T‐cell induction. This study for the first time showed the mechanism behind P. gingivalis‐ mediated intestinal inflammation where P. gingivalis indirectly induces intestinal IL9 + CD4 + T cells and inflammation by altering the gut microbiota. Understanding the mechanism of P. gingivalis ‐mediated intestinal inflammation may lead to the development of novel therapeutic approaches to alleviate the morbidity from inflammatory bowel disease patients with periodontal disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeInflammatory Bowel DiseasesPeriodontal DiseasesAnimalsCD4-Positive T-LymphocytesHumansInflammationInterleukin-9MicePorphyromonas gingivalisT-Lymphocytes

Stichwörter der Autor:innen

Porphyromonas gingivalisinflammatory bowel diseasemicrobiomeperiodontitis

Substanzen

Interleukin-9

Autor:innen und Institutionen

  • Genetics, Genomics, and Bioinformatics Program, State University of New York at Buffalo, Buffalo, New York.
  • Department of Medicine, State University of New York at Buffalo, Buffalo, New York.
  • Department of Oral Biology, State University of New York at Buffalo, Buffalo, New York.
  • Department of Microbiology and Immunology, State University of New York at Buffalo, Buffalo, New York.
  • Department of Head & Neck/Plastic & Reconstructive Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, New York.

ORCID-Profile: Rajendra P Settem, Ashu Sharma, Keith L Kirkwood

Förderung

  • NIDCR NIH HHS

Zitieren

APA

Sohn, J., Li, L., Zhang, L., Settem, R. P., Honma, K., Sharma, A., Falkner, K. L., Novak, J. M., Sun, Y., & Kirkwood, K. L. (2022). Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9‐producing CD4 + T cells. Molecular Oral Microbiology, 37(2), 42-52. https://doi.org/10.1111/omi.12359

Vancouver

Sohn J, Li L, Zhang L, Settem RP, Honma K, Sharma A, et al. Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9‐producing CD4 + T cells. Molecular Oral Microbiology. 2022;37(2):42-52. doi:10.1111/omi.12359

BibTeX
@article{Sohn2022,
  author = {Sohn, Jiho and Li, Lu and Zhang, Lixia and Settem, Rajendra P and Honma, Kiyonobu and Sharma, Ashu and Falkner, Karen L and Novak, Jan M and Sun, Yijun and Kirkwood, Keith L},
  title = {Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9‐producing CD4 + T cells},
  journal = {Molecular Oral Microbiology},
  year = {2022},
  volume = {37},
  number = {2},
  pages = {42--52},
  doi = {10.1111/omi.12359}
}
Kostenlos starten →